Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · S

S. 2244 (107th)

Prescription Drug Price Parity for Americans Act

openUnited States· United States Congress· EN

Introduced

24 April 2002

Last action

2 May 2002 · Introduced

Status

Sponsor introductory remarks on measure. (CR S3794, S3795)

Sponsors

Sen. Dorgan, Byron L. [D-ND], Sen. Jeffords, James M. [I-VT], Sen. Collins, Susan M. [R-ME], Sen. Stabenow, Debbie [D-MI], Sen. Snowe, Olympia J. [R-ME], Sen. Wellstone, Paul D. [D-MN], Sen. Levin, Carl [D-MI], Sen. Dayton, Mark [D-MN], Sen. Johnson, Tim [D-SD], Sen. Miller, Zell [D-GA], Sen. Durbin, Richard J. [D-IL], Sen. Feingold, Russell D. [D-WI]

Subjects

Healthcare

Source updated

19 August 2025

Healthcare

Summary

Prescription Drug Price Parity for Americans Act - Amends provisions of the Federal Food, Drug, and Cosmetic Act set forth in the Medicine Equity and Drug Safety Act of 2000 to: (1) direct the Secretary of Health and Human Services to promulgate regulations permitting pharmacists and wholesalers to import Food and Drug Administration (FDA)-approved prescription drugs from Canada (currently, from Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, the countries in the European Union and the European Free Trade Association, or other countries designated by the Secretary); and (2) exclude an infused or intravenously injected drug or a drug that is inhaled during surgery. Prohibits discrimination in the sale of prescription drugs by manufacturers to pharmacists or wholesalers, requiring: (1) terms as favorable as those provided to foreign purchasers; and (2) full access to drugs permitted to be imported. Continues the requirement that exported donated prescription drugs may only be reimported by the manufacturer. Permits the Secretary to waive the prohibition against importing a prescription drug or device on a case-by-case basis, particularly those from Canada that are FDA-approved and for limited personal use. Requires a study and report by the: (1) Institute of Medicine of the National Academy of Sciences on the regulatory compliance of importers of drugs; and (2) Comptroller General on how drug prices were affected.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 24 April 2002

    Introduced

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S3316-3318)

    Source: IntroReferral

  2. 24 April 2002

    Introduced

    Sponsor introductory remarks on measure. (CR S3316)

    Source: IntroReferral

  3. 24 April 2002

    Introduced

    Introduced in Senate

    Source: IntroReferral

  4. 2 May 2002

    Introduced

    Sponsor introductory remarks on measure. (CR S3794, S3795)

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in Senate (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate (text)

    Introduced in Senate · EN · 24 April 2002

    ViewDownloadOpen at official source

  • Introduced in Senate (PDF)

    Introduced in Senate · EN · 24 April 2002

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in Senate

    summary · EN · 24 April 2002

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.